Clinical Trial: Mixed formulation of fosrolapitant and palonosetron ± Dexamethasone in Combination with Prochlorperazine in Preventing Highly Emetogenic Anticancer Drugs-induced Nausea and Vomiting (China)

Posted On: 2026-09-15

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mixed formulation of fosrolapitant and palonosetron ± Dexamethasone in Combination with Prochlorperazine in Preventing Highly Emetogenic Anticancer Drugs-induced Nausea and Vomiting'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132373

Registration Time: 2026/09/14

Type: Interventional study

Primary Sponsor: Yaan People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339502

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Mixed formulation of fosrolapitant and palonosetron ± Dexamethasone in Combination with Prochlorperazine in Preventing Highly Emetogenic Anticancer Drugs-induced Nausea and Vomiting (China)